Videos de Experimentos Relacionados
¿Puede la inyección letal para la ejecución realmente ser "arreglada"?
Leonidas G Koniaris1, Jon P Sheldon, Teresa A Zimmers
1University of Miami, Miami, FL 33156, USA. LKoniaris@med.miami.edu
Lancet (London, England)
|February 6, 2007
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Moderate Aerobic Training Causes Muscle Wasting in a DMBA-Induced Sarcoma Rat Model.
International journal of molecular sciences·2026
Same author
High-fat diet and obesity each increase tumor cell proliferation and muscle wasting in experimental cancer cachexia.
American journal of physiology. Cell physiology·2026
Same author
Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancer.
JCI insight·2026
Same author
MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and Cachexia.
Cancer research communications·2025
Same author
Impaired Fatty Liver Regeneration Post-major Resection: A Mitochondrial Problem.
Shock (Augusta, Ga.)·2025
Same author
Pancreatic Cancer Induces Population-Specific Switching of Myosin Isoforms and Discrete Activation of Cachexia Genes in Skeletal Muscle Myocytes.
bioRxiv : the preprint server for biology·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026